Clinical evaluation of daratumumab in combination with lenalidomide and bortezomib and with daratumumab, bortezomib, and dexamethasone for the treatment of relapsed and refractory multiple myeloma
Yuchen ZHAO,Manting XU,Jing BAO,Liang XIA
The Journal of Practical Medicine . 2025, (18): 2913 -2919 .  DOI: 10.3969/j.issn.1006-5725.2025.18.019